Status:
COMPLETED
Carrying Out of Focus Group to Improve Cervical Screening Proposal by Vaginal Self-sampling (APACHE-4/FG).
Lead Sponsor:
University Hospital, Tours
Conditions:
Cancer Cervix
Eligibility:
FEMALE
30-65 years
Brief Summary
Despite the existence of an effective screening test (pap smear), cervical cancer is, every year in France, the cause of more than 3,000 new cases and 1,100 deaths. But, in France, 4 in 10 women are n...
Eligibility Criteria
Inclusion
- women from 30 to 65 years old
- women living in french territorial division 37 ("Indre-et-Loire")
- no pap smear made in the three last years (ideally)
Exclusion
- Follow-up in progress for positive screening
Key Trial Info
Start Date :
January 24 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 8 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03420157
Start Date
January 24 2018
End Date
February 8 2018
Last Update
July 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UH Tours
Tours, Indre-et-Loire, France, 37000